SynopsisCephalexin is a cephalosporin (SEF a low spor in) antibiotic. It works by fighting bacteria in your body. The global Cephalexine market size is expected to reach US$ 205.4 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainl.....
SynopsisCongenital neutropenia occurs when an individual has low levels of neutrophils, a type of white blood cells. Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones such as the vertebrae, ribs, and pelvis. The congenital neutr.....
SynopsisA urology ultrasound machine is a specialized medical device used to perform diagnostic imaging of the urinary tract and male reproductive system. It uses high-frequency sound waves to create detailed images of the kidneys, bladder, prostate, and other structu.....
SynopsisA face shield, an item of personal protective equipment (PPE), aims to protect the wearer's entire face (or part of it) from hazards such as flying objects and road debris, chemical splashes, or potentially infectious materials. The global PC Medical Fac.....
Synopsis A tumor necrosis factor (TNF)-α inhibitor Highlights The global Golimumab(Simponi) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
SynopsisA near-infrared vein finder is a medical device that uses near-infrared light (NIR) to locate veins in a patient's body. It helps healthcare professionals locate veins for various procedures such as drawing blood, inserting IV lines, or administering medicatio.....
Synopsis Coelenterazine and its analogs are luminescent enzyme substrates for apoaequorin and Renilla luciferase. Highlights The global Coelenterazine market was valued at US$ million in 2022 and is anticipated to reach US$.....
Synopsis Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. The global Biopharmac.....
Synopsis Global Ibuprofen for External Use market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-.....
SynopsisClofarabine is a purine nucleoside antimetabolite in Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Evoltra market was valued at US$ 251 million in 2023 and is anticipated to reach US$ 428.6 million by 2030, w.....
